BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 3872883)

  • 1. Endothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex.
    McCarroll DR; Levin EG; Montgomery RR
    J Clin Invest; 1985 Apr; 75(4):1089-95. PubMed ID: 3872883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease.
    McCarroll DR; Ruggeri ZM; Montgomery RR
    J Lab Clin Med; 1984 May; 103(5):704-11. PubMed ID: 6609219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II.
    Fay PJ; Kawai Y; Wagner DD; Ginsburg D; Bonthron D; Ohlsson-Wilhelm BM; Chavin SI; Abraham GN; Handin RI; Orkin SH
    Science; 1986 May; 232(4753):995-8. PubMed ID: 3486471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
    de Romeuf C; Mazurier C
    Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet von Willebrand's antigen II: active release by aggregating agents and a marker of platelet release reaction in vivo.
    Scott JP; Montgomery RR
    Blood; 1981 Dec; 58(6):1075-80. PubMed ID: 6975640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired von Willebrand's disease in association with Wilm's tumor: regression following treatment.
    Scott JP; Montgomery RR; Tubergen DG; Hays T
    Blood; 1981 Oct; 58(4):665-9. PubMed ID: 6268230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor storage and multimerization: 2 independent intracellular processes.
    Haberichter SL; Fahs SA; Montgomery RR
    Blood; 2000 Sep; 96(5):1808-15. PubMed ID: 10961880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor.
    Lynch DC; Zimmerman TS; Ling EH; Browning PJ
    J Clin Invest; 1986 Jun; 77(6):2048-51. PubMed ID: 3486890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen stimulates von Willebrand factor production by cultured endothelial cells.
    Harrison RL; McKee PA
    Blood; 1984 Mar; 63(3):657-64. PubMed ID: 6607757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall].
    Meyer D
    Nouv Rev Fr Hematol (1978); 1982; 24(3):145-51. PubMed ID: 6752879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.
    Zimmerman TS; Voss R; Edgington TS
    J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subunit composition of oligomeric human von Willebrand factor.
    Lynch DC; Zimmerman TS; Kirby EP; Livingston DM
    J Biol Chem; 1983 Nov; 258(21):12757-60. PubMed ID: 6605344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of DDAVP on plasma levels of von Willebrand antigen II in normal individuals and patients with von Willebrand's disease.
    McCarroll DR; Ruggeri ZM; Montgomery RR
    Blood; 1984 Mar; 63(3):532-5. PubMed ID: 6607754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of platelet von Willebrand factor antigen.
    Thomas KB; Firkin BG; Howard MA
    Haemostasis; 1987; 17(4):217-25. PubMed ID: 3623266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor.
    Jones TR; Kao KJ; Pizzo SV; Bigner DD
    Am J Pathol; 1981 May; 103(2):304-8. PubMed ID: 6786103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels.
    Vischer UM; Ingerslev J; Wollheim CB; Mestries JC; Tsakiris DA; Haefeli WE; Kruithof EK
    Thromb Haemost; 1997 Feb; 77(2):387-93. PubMed ID: 9157601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells.
    Wagner DD; Fay PJ; Sporn LA; Sinha S; Lawrence SO; Marder VJ
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):1955-9. PubMed ID: 3494248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.